The FDA has expanded the approved uses of the CellSearch® System to monitor metastatic colorectal cancer. CellSearch finds and counts circulating tumor cells in the bloodstream.
Circulating tumor cells are shed from the cancerous tumor. They can indicate treatment effectiveness and predict cancer progression and overall survival. CellSearch is designed to be used together with more traditional imaging to help make decisions about what treatments to continue.
The CellSearch device was originally approved by the FDA in 2004 to monitor metastatic breast cancer
Technorati tags: circulating tumor cells
Leave a Reply
Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. FightCRC is not responsible for the medical accuracy of any comments left by persons other than FightCRC staff members. FightCRC staff members monitor comments and may respond publicly where appropriate.
Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.
We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).